Bacterial urinary tract infections represent the most common type of nosocomial infection. In many cases, the ability of bacteria to both establish and maintain these infections is directly related to biofilm formation on indwelling devices or within the urinary tract itself. This chapter will focus on the role of biofilm formation in urinary tract infections with an emphasis on Gram-negative bacteria. The clinical implications of biofilm formation will be presented along with potential strategies for prevention. In addition, the role of specific pathogenencoded functions in biofilm development will be discussed.
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Abraham JM, Freitag CS, Clements JR, Eisenstein BI (1985) An invertible element of DNA controls phase variation of type 1 fimbriae of Escherichia coli. Proc Natl Acad Sci U S A 82:5724–5727
Abraham SN, Goguen JD, Sun D, Klemm P, Beachey EH (1987) Identification of two ancillary subunits of Escherichia coli type 1 fimbriae by using antibodies against synthetic oligopeptides of fim gene products. J Bacteriol 169:5530–5536
Abrahams HM, Stoller ML (2003) Infection and urinary stones. Curr Opin Urol 13:63–67
Allison C, Lai HC, Hughes C (1992) Co-ordinate expression of virulence genes during swarm-cell differentiation and population migration of Proteus mirabilis. Mol Microbiol 6:1583–1591
Anderson GG, Palermo JJ, Schilling JD, Roth R, Heuser J, Hultgren SJ (2003) Intracellular bacterial biofilm-like pods in urinary tract infections. Science 301:105–107
Bagshaw SM, Laupland KB (2006) Epidemiology of intensive care unit acquired urinary tract infections. Curr Opin Infect Dis 19:67–71
Bahrani FK, Mobley HL (1994) Proteus mirabilis MR/P fimbrial operon: genetic organization, nucleotide sequence, and conditions for expression. J Bacteriol 176:3412–3419
Bahrani-Mougeot FK, Buckles EL, Lockatell CV, Hebel JR, Johnson DE, Tang CM, Donnenberg MS (2002) Type 1 fimbriae and extracellular polysaccharides are preeminent uropathogenic Escherichia coli virulence determinants in the murine urinary tract. Mol Microbiol 45:1079–1093
Baorto DM, Gao Z, Malaviya R, Dustin ML, van der Merwe A, Lublin DM, Abraham SN (1997) Survival of FimH-expressing enterobacteria in macrophages relies on glycolipid traffic. Nature 389:636–639
Beloin C, Michaelis K, Lindner K, Landini P, Hacker J, Ghigo JM, Dobrindt U (2006) The transcriptional antiterminator RfaH represses biofilm formation in Escherichia coli. J Bacteriol 188:1316–1331
Bian Z, Normark S (1997) Nucleator function of CsgB for the assembly of adhesive surface organelles in Escherichia coli. EMBO J 16:5827–5836
Bichler KH, Eipper E, Naber K Braun V Zimmmermann R, Lahme S (2002) Urinary infection stones. Int J Antimicrob Agents 19:488–498
Blomfield IC, Calie PJ, Eberhardt KJ, McClain MS, Eisenstein BI (1993) Lrp stimulates phase variation of type 1 fimbriation in Escherichia coli K-12. J Bacteriol 175:27–36
Blomfield IC, Kulasekara DH, Eisenstein BI (1997) Integration host factor stimulates both FimB- and FimE-mediated site-specific DNA inversion that controls phase variation of type 1 fimbriae expression in Escherichia coli. Mol Microbiol 23:705–717
Blumer C, Kleefeld A, Lehnen D, Heintz M, Dobrindt U, Nagy G, Michaelis K, Emody L, Polen T, Rachel R, Wendisch VF, Unden G (2005) Regulation of type 1 fimbriae synthesis and biofilm formation by the transcriptional regulator LrhA of Escherichia coli. Microbiology 151:3287–3298
Boddicker JD, Anderson RA, Jagnow J, Clegg S (2006) Signature-tagged mutagenesis of Klebsiella pneumoniae to identify genes that influence biofilm formation on extracellular matrix material. Infect Immun 74:4590–4597
Brinton CC Jr (1965) The structure, function, synthesis and genetic control of bacterial pili and a molecular model for DNA, RNA transport in Gram-negative bacteria. Trans N Y Acad Sci 27:1003–1054
Burton E, Gawande PV, Yakandawala N, LoVetri K, Zhanel GG, Romeo T, Friesen AD, Madhyastha S (2006) Antibiofilm activity of GlmU enzyme inhibitors against catheter-associated uropathogens. Antmicrob Agents Chemother 50:1835–1840
Clapham L, McLean RJC, Nickel JC, Downey J, Costerton JW (1990) The influence of bacteria on struvite crystal habit and its importance in urinary stone formation. J Crystal Growth 104:475–484
Choog S, Whitfield H (2000) Biofilms and their role in infections in urology. BJU Int 86:935–941
Clegg S, Gerlach GF (1987) Enterobacterial fimbriae. J Bacteriol 169:934–938
Connell I, Agace W, Klemm P, Schembri M, Marild S, Svanborg C (1996) Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. Proc Natl Acad Sci U S A 93:9827–9832
Danese PN, Pratt LA, Dove SL, Kolter R (2000) The outer membrane protein, antigen 43, mediates cell-to-cell interactions within Escherichia coli biofilms. Mol Microbiol 37:424–432
Deflaun MF, Marshall BM, Kulle EP, Levy SB (1994) Tn 5 insertion mutants of Pseudomonas fluorescens defective in adhesion to soil and seeds. Appl Environ Microbiol 60:2637–2642
Denamur E, Bonacorsi S, Giraud A, Duriez P, Hilali F, Amorin C, Bingen E, Andremont A, Picard B, Taddei F, Matic I (2002) High frequency of mutator strains among human uropathogenic Escherichia coli isolates. J Bacteriol 184:605–609
Diderichsen B (1980) flu, a metastable gene controlling surface properties of Escherichia coli. J Bacteriol 141:858–867
Di Martino P, Cafferini N, Joly B, Darfeuillle-Michaud A (2003) Klebsiella pneumoniae type 3 pili facilitate adherence and biofilm formation on abiotic surfaces. Res Microbiol 154:9–16
Domingue GJ, Hellstrom WG (1998) Prostatitis. Clin Microbiol Rev 11:604–613
Donato GM, Lelivelt MJ, Kawula TH (1997) Promoter-specific repression of fimB expression by the Escherichia coli nucleoid-associated protein H-NS. J Bacteriol 179:6618–6625
Donlan RW (2001) Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis 33:1387–1392
Donlan RM, Costerton JW (2002) Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15:167–193
Dumanski AJ, Hedelin H, Edin-Liljegren A, Beauchemin D, McLean RJC (1994) Unique ability of the Proteus mirabilis capsule to enhance mineral growth in infectious urinary calculi. Infect Immun 62:2998–3003
Duncan MJ, Li GJ, Shin JS, Carson JL, Abraham SN (2004) Bacterial penetration of bladder epithelium through lipid rafts. J Biol Chem 279:18944–18951
Eden CS, Hansson HA (1978) Escherichia coli pili as possible mediators of attachment to human urinary tract epithelial cells. Infect Immun 21:229–237
Elliott TS, Reed L, Slack RC, Bishop MC (1985) Bacteriology and ultrastructure of the bladder in patients with urinary tract infections. J Infect 11:191–199
Emori TG, Gaynes RP (1993) An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 6:428–442
Eto DS, Sundsbak JL, Mulvey MA (2006) Actin-gated intracellular growth and resurgence of uropathogenic Escherichia coli. Cell Microbiol 8:704–717
Foxman B, Zhang L, Palin K, Tallman P, Marrs CF (1995) Bacterial virulence characteristics of Escherichia coli isolates from first-time urinary tract infection. J Infect Dis 171:1514–1521
Foxman B (2003) Epidemiology of urinary tract infections: incidence, morbidity and economic costs. Dis Mon 49:53–70
Gally DL, Leathart J, Blomfield IC (1996) Interaction of FimB, FimE with the fim switch that controls the phase variation of type 1 fimbriae in Escherichia coli K-12. Mol Microbiol 21:725–738
Gally DL, Rucker TJ, Blomfield IC (1994) The leucine-responsive regulatory protein binds to the fim switch to control phase variation of type 1 fimbrial expression in Escherichia coli K-12. J Bacteriol 176:5665–5672
Griffith DP, Musher DM, Itin C (1976) Urease. The primary cause of infection-induced urinary stones. Invest Urol 13:346–350
Gunther IN, Snyder JA, Lockatell V, Blomfield I, Johnson DE, Mobley HL (2002) Assessment of virulence of uropathogenic Escherichia coli type 1 fimbrial mutants in which the invertible element is phase-locked on or off. Infect Immun 70:3344–3354
Gunther NW, Lockatell V, Johnson DE, Mobley HL (2001) In vivo dynamics of type 1 fimbria regulation in uropathogenic Escherichia coli during experimental urinary tract infection. Infect Immun 69:2838–2846
Haagmans W, van der Woude M (2000) Phase variation of Ag43 in Escherichia coli: Dam-dependent methylation abrogates OxyR binding and OxyR-mediated repression of transcription. Mol Microbiol 35:877–887
Hagberg L, Jodal U, Korhonen TK, Lidin-Janson G, Lindberg U, Svanborg Eden C (1981) Adhesion, hemagglutination, and virulence of Escherichia coli causing urinary tract infections. Infect Immun 31:564–570
Haraoka M, Hang L, Frendeus B, Godaly G, Burdick M, Strieter R, Svanborg C (1999) Neutrophil recruitment and resistance to urinary tract infection. J Infect Dis 180:1220–1229
Hasman H, Chakraborty T, Klemm P (1999) Antigen-43-mediated autoaggregation of Escherichia coli is blocked by fimbriation. J Bacteriol 181:4834–4841
Henderson IR, Owen P (1999) The major phase-variable outer membrane protein of Escherichia coli structurally resembles the immunoglobulin A1 protease class of exported protein and is regulated by a novel mechanism involving Dam and oxyR. J Bacteriol 181:2132–2141
Hooton TM, Stamm WE (1997) Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am 11:551–581
Hultgren SJ, Porter TN, Schaeffer AJ, Duncan JL (1985) Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli. Infect Immun 50:370–377
Hvidberg H, Struve C, Krogfelt KA, Christensen N, Rasmussen SN, Frimodt-Moller N (2000) Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies. Antimicrob Agents Chemother 44:156–163
Jackson DW, Simecka JW, Romeo T (2002) Catabolite repression of Escherichia coli biofilm formation. J Bacteriol 184:3406–3410
Jagnow J, Clegg S (2003) Klebsiella pneumoniae MrkD-mediated biofilm formation on extracellular matrix- and collagen coated surfaces. Microbiology 149:2397–2405
Jansen AM, Lockatell V, Johnson DE, Mobley HLT (2004) Mannose resistant Proteus like fimbriae are produced by most Proteus mirabilis strains infecting the urinary tract, dictate the in-vivo localization of bacteria and contribute to biofilm formation. Infect Immun 72:7294–7305
Johnson DE, Lockatell CV, Russell RG, Hebel JR, Island MD, Stapleton A, Stamm WE, Warren JW (1998) Comparison of Escherichia coli strains recovered from human cystitis and pyelonephritis infections in transurethrally challenged mice. Infect Immun 66:3059–3065
Johnson JR (1991) Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 4:80–128
Jones BV, Mahenthiralingam E, Sabbuba NA, Stickler DJ (2005) Role of swarming in the formation of crystalline Proteus mirabilis biofilms on urinary catheters. J Med Microbiol 54:807–813
Jones CH, Pinkner JS, Nicholes AV, Slonim LN, Abraham SN, Hultgren SJ (1993) FimC is a periplasmic PapD-like chaperone that directs assembly of type 1 pili in bacteria. Proc Natl Acad Sci U S A 90:8397–8401
Jones CH, Pinkner JS, Roth R, Heuser J, Nicholes AV, Abraham SN, Hultgren SJ (1995) FimH adhesin of type 1 pili is assembled into a fibrillar tip structure in the Enterobacteriaceae. Proc Natl Acad Sci. U S A 92:2081–2085
Jost SP (1989) Cell cycle of normal bladder urothelium in developing and adult mice. Virchows Archiv 57:27–36
Justice SS, Hung C, Theriot JA, Fletcher DA, Anderson GG, Footer MJ, Hultgren SJ (2004) Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc Natl Acad Sci U S A 101:1333–1338
Kajander EO, Ciftcioglu N (1998) Nanobacteria: an alternative mechanism for pathogenic intra- and extracellular calcification and stone formation. Proc Natl Acad Sci U S A 95:8274–8279
Kalsi J, Arya M, Wilson P, Mundy A (2003) Hospital acquired urinary tract infection. Int J Clin Prac 57:388–391
Kanamaru S, Kurazono H, Terai A, Monden K, Kumon H, Mizunoe Y, Ogawa O, Yamamoto S (2006) Increased biofilm formation in Escherichia coli isolated from acute prostatitis. Int J Antimicrob Agents S28:S21–S25
Kikuchi T, Mizunoe Y, Takade A, Naito S, Yoshida S (2005) Curli fibers are required for development of biofilm architecture in Escherichia coli K-12 and enhance bacterial adherence to human uroepithelial cells. Microbiol Immunol 49:875–884
Kjaergaard K, Schembri MA, Ramos C, Molin S, Klemm P (2000) Antigen 43 facilitates formation of multispecies biofilms. Environ Microbiol 2:695–702
Klemm P (1986) Two regulatory fim genes, fimB and fimE, control the phase variation of type 1 fimbriae in Escherichia coli. EMBO J 5:1389–1393
Klemm P, Christiansen G (1987) Three fim genes required for the regulation of length and mediation of adhesion of Escherichia coli type 1 fimbriae. Mol Gen Genet 208:439–445
Klemm P, Christiansen G (1990) The fimD gene required for cell surface localization of Escherichia coli type 1 fimbriae. Mol Gen Genet 220:334–338
Klemm P, Hjerrild L, Gjermansen M, Schembri MA (2004) Structure-function analysis of the self-recognizing Antigen 43 autotransporter protein from Escherichia coli. Mol Microbiol 51:283–296
Knirel YA, Vinogradov EV, Shashkov AS, Sidorczyk Z, Rozalski A, Korber DR, Lawrence JR, Caldwell DE (1994) Effect of motility on surface colonization and reproductive success of Pseudomonas fluorescens in dual-dilution continuous culture and batch culture systems. Appl Environ Microbiol 60:1421–1429
Krogfelt KA, Bergmans H, Klemm P (1990) Direct evidence that the FimH protein is the mannose-specific adhesin of Escherichia coli type 1 fimbriae. Infect Immun 58:1995–1998
Labat F, Pradillon O, Garry L, Peuchmaur M, Fantin B, Denamur E (2005) Mutator phenotype confers advantage in Escherichia coli chronic urinary tract infection pathogenesis. FEMS Immunol Med Microbiol 44:317–321
Lane MC, Lockatell V, Monterosso G, Lamphier D, Weinert J, Hebel JR, Johnson DE, Mobley HL (2005) Role of motility in the colonization of uropathogenic Escherichia coli in the urinary tract. Infect Immun 73:7644–7656
Langermann S, Mollby R, Burlein JE, Palaszynski SR, Auguste CG, DeFusco A, Strouse R, Schenerman MA, Hultgren SJ, Pinkner JS, Winberg J, Guldevall L, Soderhall M, Ishikawa K, Normark S, Koenig S (2000) Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli. J Infect Dis 181:774–778
Langermann S, Palaszynski S, Barnhart M, Auguste G, Pinkner JS, Burlein J, Barren P, Koenig S, Leath S, Jones CH, Hultgren SJ (1997) Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science 276:607–611
Langstraat J, Bohse M, Clegg S (2001) Type 3 fimbrial shaft (MrkA) of Klebsiella pneumoniae, but not the fimbral adhesion (MrkD), facilitates biofilm formation. Infect Immun 69:5805–5812
Lehnen D, Blumer C, Polen T, Wackwitz B, Wendisch VF, Unden G (2002) LrhA as a new transcriptional key regulator of flagella, motility and chemotaxis genes in Escherichia coli. Mol. Microbiol 45:521–532
Li X, Rasko DA, Lockatell CV, Johnson DE, Mobley HL (2001) Repression of bacterial motility by a novel fimbrial gene product. EMBO J 20:4854–4862
Li X, Lockatell CV, Johnson DE, Mobley HL (2002) Identification of MrpI as the sole recombinase that regulates the phase variation of MR/P fimbria, a bladder colonization factor of uropathogenic Proteus mirabilis. Mol Microbiol 45:865–874
Li X, Zhao HJ, Lockatell CV, Drachenberg CB, Johnson DE, Mobley HLT (2002) Visualization of Proteus mirabilis within the matrix of urease-induced bladder stones during experimental urinary tract infection. Infect Immun 70:389–394
Li X, Lockatell CV, Johnson DE, Lane MC, Warren JW, Mobley HL (2004) Development of an intranasal vaccine to prevent urinary tract infection by Proteus mirabilis. Infect Immun 72:66–75
Maki DG, Tambyah PA (2001) Engineering out the risk of infection with urinary catheters. Emerg Infect Dis 7:342–347
Malaviya R, Gao Z, Thankavel K, van der Merwe PA, Abraham SN (1999) The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48. Proc Natl Acad Sci U S A 96:8110–8115
Marrs CF, Zhang L, Foxman B (2005) Escherichia coli mediated urinary tract infections: are there distinct uropathogenic E. coli (UPEC) pathotypes? FEMS Microbiol Lett 252:183–190
Martinez JJ, Mulvey MA, Schilling JD, Pinkner JS, Hultgren SJ (2000) Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. EMBO J 19:2803–2812
Maurer L, Orndorff PE (1987) Identification and characterization of genes determining receptor binding and pilus length of Escherichia coli type 1 pili. J Bacteriol 169:640–645
McClain MS, Blomfield IC, Eisenstein BI (1991) Roles of fimB and fimE in site-specific DNA inversion associated with phase variation of type 1 fimbriae in Escherichia coli. J Bacteriol 173:5308–5314
McLean RJ, Nickel JC, Beveridge TJ, Costerton JW (1989) Observations of the ultrastructure of infected kidney stones. J Med Microbiol 29:1–7
McTaggart LA, Rigby RC, Elliott TS (1990) The pathogenesis of urinary tract infections associated with Escherichia coli, Staphylococcus saprophyticus and S epidermidis. J Med Microbiol 32:135–141
Mireles JR, Toguchi A, Harshey RM (2001) Salmonella enterica serovar typhimurium swarming mutants with altered biofilm forming properties: surfactin inhibits biofilm formation. J Bacteriol 183:5848–5854
Morris NS, Stickler DJ, Winters C (1997) Which indwelling catheters resist encrustation by Proteus mirabilis biofilms? Br J Urol 80:58–63
Morris N, Stickler DJ (1998) The effect of urease inhibitors on the encrustation of urethral catheters. Urol Res 26:275–279
Morris NS, Stickler DJ, McLean RJC (1999) The development of bacterial biofilms on indwelling urethral catheters. World J Urol 17:345–350
Morris NS, Stickler DJ (2001) Does drinking cranberry juice produce urine inhibitory to the development of crystalline, catheter blocking Proteus mirabilis biofilms. BJU Int 88:192–197
Mulvey MA, Lopez-Boado YS, Wilson CL, Roth R, Parks WC, Heuser J, Hultgren SJ (1998) Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 282:1494–1497
Mulvey MA, Schilling JD, Hultgren SJ (2001) Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun 69:4572–4579
Nickel JC, Gristina AG, Costerton JW (1985) Electron microscopic study of an infected Foley catheter. Can J Surg 28:50–51
Nickel JC, Olson M, McLean RJ, Grant SW, Costerton JW (1987) An ecological study of infected urinary stone genesis in an animal model. Br J Urol 59:21–30
Nickel JC, Downey JA, Costerton JW (1989) Ultrastructural study of microbiologic colonization of urinary catheters. 134:284–291
Nickel JC, Costerton JW (1992) Coagulase-negative Staphylococcus in chronic prostatitis. J Urol 147:398–400
Nickel JC, Costerton JW (1993) Bacterial localization in antibiotic-refractory chronic bacterial prostatitis. Prostate 23:107–114
Nickel C, Costerton W, McClean RJC, Olson M (1994) Bacterial biofilms: influence on the pathogenesis, diagnosis and treatment of urinary tract infections. Antimicrob Chemother 33:31–41
Nicolle LE (2005) Catheter-related urinary tract infection. Drugs Aging 22:627–639
O’Gara J, Dorman CJ (2000) Effects of local transcription and H-NS on inversion of the fim switch of Escherichia coli. Mol Microbiol 36:457–466
O’Toole GA, Kolter R (1998a) Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol Microbiol 30:295–304
O’Toole GA, Kolter R (1998b) Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol Microbiol 28:449–461
Oelschlaeger TA, Dobrindt U, Hacker J (2002) Virulence factors of uropathogens. Curr Opin Urol 12:33–38
Ohkawa M, Sugata T, Sawaki M, Nakashima T, Fuse H, Hisazumi H (1990) Bacterial and crystal adherence to the surfaces of indwelling urethral catheters. J Urol 143:717–721
Olsen A, Jonsson A, Normark S (1989) Fibronectin binding mediated by a novel class of surface organelles on Escherichia coli. Nature 338:652–655
Olsen PB, Klemm P (1994) Localization of promoters in the fim gene cluster and the effect of H-NS on the transcription of fimB and fimE. FEMS Microbiol Lett 116:95–100
Owen P, Meehan M, de Loughry-Doherty H, Henderson I (1996) Phase-variable outer membrane proteins in Escherichia coli. FEMS Immunol Med Microbiol 16:63–76
Parsek MR, Singh PK (2003) Bacterial biofilms: an emerging link to disease pathogenesis. Annu Rev Microbiol 57:677–701
Pak J, Pu Y, Zhang ZT, Hasty DL, Wu XR (2001) Tamm-Horsfall protein binds to type 1 fimbriated Escherichia coli and prevents E coli from binding to uroplakin Ia and Ib receptors. J Biol Chem 276:9924–9930
Pratt LA, Kolter R (1998) Genetic analysis of Escherichia coli biofilm formation: roles of flagella, motility, chemotaxis and type I pili. Mol Microbiol 30:285–293
Prigent-Combaret C, Prensier G, Le Thi TT, Vidal O, Lejeune P, Dorel C (2000) Developmental pathway for biofilm formation in curli-producing Escherichia coli strains: role of flagella, curli and colanic acid. Environ Microbiol 2:450–464
Radziejewska J, Kaca W (1993) Structural study of O-specific polysaccharides of Proteus. J Carbohydrate Chem 12:379–414
Rather PN (2005) Swarmer cell differentiation in Proteus mirabilis. Environ Microbiol 7:1065–1073
Reid G, Denstedt JD, Yang YS, Lam D, Nause C (1992) Microbial adhesion and biofilm formation on urethral stents in-vitro and in-vivo. J Urol 148:1592–1594
Reid G (1999) Biofilms in infectious disease and on medical devices. Int J Antimicrob Agents 11:223–239
Reisner A, Haagensen JAJ, Schembri MA, Zechner EL, Molin S (2003) Development and maturation of Escherichia coli K-12 biofilms. Mol Microbiol 48:933–946
Roche A, McFadden J, Owen P (2001) Antigen 43, the major phase-variable protein of the Escherichia coli outer membrane, can exist as a family of proteins encoded by multiple alleles. Microbiology 147:161–169
Romih R, Veranic P, Jezernik K (1999) Actin filaments during terminal differentiation of urothelial cells in the rat urinary bladder. Histochem Cell Biol 112:375–380
Rosch W, Lugauer S (1999) Catheter associated infections in urology: possible use of silver impregnated catheters and the Erlanger silver catheter 27:S74–S77
Russell PW, Orndorff PE (1992) Lesions in two Escherichia coli type 1 pilus genes alter pilus number and length without affecting receptor binding. J Bacteriol 174:5923–5935
Sabbuba N, Hughes G, Stickler DJ (2002) The migration of Proteus mirabilis and other urinary tact pathogens over Foley catheters. BJU Int 89:55–60
Schaeffer AJ, Schwan WR, Hultgren SJ, Duncan JL (1987) Relationship of type 1 pilus expression in Escherichia coli to ascending urinary tract infections in mice. Infect Immun 55:373–380
Schembri MA, Christiansen G, Klemm P (2001) FimH-mediated autoaggregation of Escherichia coli. Mol Microbiol 41:1419–1430
Schembri MA, Dalsgaard D, Klemm P (2004) Capsule shields the function of short bacterial adhesins. J Bacteriol 186:1249–1257
Schembri MA, Hjerrild L, Gjermansen M, Klemm P (2003a) Differential expression of the Escherichia coli autoaggregation factor antigen 43. J Bacteriol 185:2236–2242
Schembri MA, Kjaergaard K, Klemm P (2003b) Global gene expression in Escherichia coli biofilms. Mol Microbiol 48:253–267
Schembri MA, Klemm P (2001a) Biofilm formation in a hydrodynamic environment by novel FimH variants and ramifications for virulence. Infect Immun 69:1322–1328
Schembri MA, Klemm P (2001b) Coordinate gene regulation by fimbriae-induced signal transduction. EMBO J 20:3074–3081
Schembri MA, Ussery DW, Workman C, Hasman H, Klemm P (2002) DNA microarray analysis of fim mutations in Escherichia coli. Mol Genet Genomics 267:721–729
Shin JS, Gao Z, Abraham SN (2000) Involvement of cellular caveolae in bacterial entry into mast cells. Science 289:785–788
Silverstein A, Donatucci CF (2003) Bacterial biofilms and implantable prosthetic devices. Int J Impot Res 5:S150–S154
Snyder JA, Lloyd AL, Lockatell CV, Johnson DE, Mobley HL (2006) Role of phase variation of type 1 fimbriae in a uropathogenic Escherichia coli cystitis isolate during urinary tract infection. Infect Immun 74:1387–1393
Sobel JD (1997) Pathogenesis of urinary tract infection. Role of host defenses. Infect Dis Clin North Am 11:531–549
Sokurenko EV, Chesnokova V, Doyle RJ, Hasty DL (1997) Diversity of the Escherichia coli type 1 fimbrial lectin. Differential binding to mannosides and uroepithelial cells. J Biol Chem 272:17880–17886
Sokurenko EV, Chesnokova V, Dykhuizen DE, Ofek I, Wu XR, Krogfelt KA, Struve C, Schembri MA, Hasty DL (1998) Pathogenic adaptation of Escherichia coli by natural variation of the FimH adhesin. Proc Natl Acad Sci U S A 95:8922–8926
Sokurenko EV, Courtney HS, Maslow J, Siitonen A, Hasty DL (1995) Quantitative differences in adhesiveness of type 1 fimbriated Escherichia coli due to structural differences in fimH genes. J Bacteriol 177:3680–3686
Sokurenko EV, Courtney HS, Ohman DE, Klemm P, Hasty DL (1994) FimH family of type 1 fimbrial adhesins: functional heterogeneity due to minor sequence variations among fimH genes. J Bacteriol 176:748–755
Stickler D, Ganderton L, King J, Nettleton J, Winters C (1993) Proteus mirabilis biofilms and the encrustation of urethral catheters. Urol Res 21:407–411
Stickler D, Morris N, Moreno MC, Sabbuba N (1998) Studies on the formation of crystalline bacterial biofilms on urethral catheters. Eur J Clin Microbiol Infect Dis 17:649–652
Stickler D, Hughes G (1999) Ability of Proteus mirabilis to swarm over urethral catheters. Eur J Clin Microbiol Infect Dis 18:206–208
Stickler DJ (2002) Susceptibility of antibiotic resistant Gram-negative bacteria to biocides: a perspective from the study of catheter biofilms. Symp Ser Appl Microbiol 31:163S–170S
Stickler DJ, Jones GL, Russell AD (2003a) Control of encrustation and blockage of Foley catheters. Lancet 361:1435–1437
Stickler DJ, Young R, Jones G, Sabbuba N, Morris N (2003b) Why are Foley catheters so vulnerable to encrustation and blockage by crystalline bacterial biofilm? Urol Res 31:306–311
Struve C, Krogfelt KA (1999) In vivo detection of Escherichia coli type 1 fimbrial expression and phase variation during experimental urinary tract infection. Microbiology 145:2683–2690
Sun TT, Zhao H, Provet J, Aebi U, Wu XR (1996) Formation of asymmetric unit membrane during urothelial differentiation. Mol Biol Rep 23:3–11
Svanborg C, Bergsten G, Fischer H, Frendeus B, Godaly G, Gustafsson E, Hang L, Hedlund M, Karpman D, Lundstedt AC, Samuelsson M, Samuelsson P, Svensson M, Wullt B (2001) The ‘innate’ host response protects and damages the infected urinary tract. Ann Med 33:563–570
Takeuchi H, Takayama H, Konishi T, Tomoyoshi T (1984) Scanning electron microscopy detects bacteria within infection stones. J Urol 132:67–69
Tenke P, Kovacs B, Jackel M, Nagy E (2006) The role of biofilm infection in urology. World J Urol 24:13–20
Torzewska A, Staczek P, Rozalski A (2003) Crystallization of urine mineral components may depend on the chemical nature of Proteus endotoxin polysaccharides. J Med Microbiol 52:471–477
Trautner BW, Darouiche RO (2004) Role of biofilm in catheter-associated urinary tract infection. Am J Infect Control 32:177–183
Ulett GC, Webb RI, Schembri MA (2006) Antigen-43-mediated autoaggregation impairs motility in Escherichia coli. Microbiology 152:2101–2110
Valenski ML, Harris SL, Spears PA, Horton JR, Orndorff PE (2003) The product of the fimI gene is necessary for Escherichia coli type 1 pilus biosynthesis. J Bacteriol 185:5007–5011
Vidal O, Longin R, Prigent-Combaret C, Dorel C, Hooreman M, Lejeune P (1998) Isolation of an Escherichia coli K-12 mutant strain able to form biofilms on inert surfaces: involvement of a new ompR allele that increases curli expression. J Bacteriol 180:2442–2449
Wagenlehner FME, Naber KG (2006) The treatment of bacterial urinary tract infections: presence and future. Eur Urol 49:235–244
Waldron DE, Owen P, Dorman CJ (2002) Competitive interaction of the OxyR DNA-binding protein and the Dam methylase at the antigen 43 gene regulatory region in Escherichia coli. Mol Microbiol 44:509–520
Watnick PI, Lauriano CM, Klose KE, Croal L, Kolter R (2001) The absence of a flagellum leads to altered colony morphology, biofilm development and virulence in Vibrio cholerae O139. Mol Microbiol 39:223–235
Wold AE, Mestecky J, Tomana M, Kobata A, Ohbayashi H, Endo T, Eden CS (1990) Secretory immunoglobulin A carries oligosaccharide receptors for Escherichia coli type 1 fimbrial lectin. Infect Immun 58:3073–3077
Wright KJ, Seed PC, Hultgren SJ (2005) Uropathogenic Escherichia coli flagella aid in efficient urinary tract colonization. Infect Immun 73:7657–7668
Wu XR, Sun TT, Medina JJ (1996) In vitro binding of type 1-fimbriated Escherichia coli to uroplakins Ia and Ib: relation to urinary tract infections. Proc Natl Acad Sci U S A 93:9630–9635
Yamamoto S, Tsukamoto T, Terai A, Kurazono H, Takeda Y, Yoshida O (1995) Distribution of virulence factors in Escherichia coli isolated from urine of cystitis patients. Microbiol Immunol 39:401–404
Zheng M, Aslund F, Storz G (1998) Activation of the OxyR transcription factor by reversible disulfide bond formation. Science 279:1718–1721
Zhou G, Mo WJ, Sebbel P, Min G, Neubert TA, Glockshuber R, Wu XR, Sun TT, Kong XP (2001) Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro FimH binding. J Cell Sci 114:4095–4103
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hatt, J.K., Rather, P.N. (2008). Role of Bacterial Biofilms in Urinary Tract Infections. In: Romeo, T. (eds) Bacterial Biofilms. Current Topics in Microbiology and Immunology, vol 322. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-75418-3_8
Download citation
DOI: https://doi.org/10.1007/978-3-540-75418-3_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-75417-6
Online ISBN: 978-3-540-75418-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)